Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE

Summary by Watauga Democrat
YONGIN, South Korea, Aug. 21, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that it has revealed the delivery mechanism of Hunterase (idursulfase beta), a recombinant enzyme replacement therapy for Hunter syndrome…

23 Articles

keenesentinel.comkeenesentinel.com
+21 Reposted by 21 other sources
Center

GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE

YONGIN, South Korea, Aug. 21, 2025 /PRNewswire/ -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that it has revealed the delivery mechanism of Hunterase (idursulfase beta), a recombinant enzyme replacement therapy for Hunter syndrome…

Read Full Article
The AI JournalThe AI Journal

GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal

Open the article to view the coverage from The AI Journal

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 58% of the sources are Center
58% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Thursday, August 21, 2025.
Sources are mostly out of (0)

Similar News Topics

Artificial Intelligence icon

Artificial Intelligence

South Korea icon

South Korea

News
For You
SearchBlindspotLocal